PERRY MICHAEL S
Insider CIK 1250379 · RCEL Chief Executive Officer, Director · PARD President & CMO · ARWR Director · APHB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2026-08-18 | 2026-08-20 | 11,600 | $87.30 | $1.01M | 111,459 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2026-08-18 | 2026-08-20 | 11,600 | $87.30 | $1.01M | 111,459 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2025-12-16 | 2025-12-18 | 7,819 | — | $0 | 123,059 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2025-12-05 | 2025-12-09 | 16,250 | $61.03 | $991.7K | 115,240 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2024-12-18 | 2024-12-20 | 16,733 | $22.99 | $384.7K | 131,490 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2023-12-15 | 2023-12-19 | 14,987 | $25.41 | $380.8K | 114,754 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award deriv | 2023-01-10 | 2023-01-11 | 4,593 | — | $0 | 4,593 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2023-01-10 | 2023-01-11 | 7,867 | — | $0 | 99,767 | SEC↗ |
| RCEL AVITA Medical, Inc. | M Exercise deriv | 2022-11-21 | 2022-11-22 | 150,000 | — | $0 | 0 | SEC↗ |
| RCEL AVITA Medical, Inc. | M Exercise | 2022-11-21 | 2022-11-22 | 150,000 | $5.99 | $898.5K | 379,543 | SEC↗ |
| RCEL AVITA Medical, Inc. | S Sale | 2022-11-21 | 2022-11-22 | 150,000 | $7.18 | $1.08M | 229,543 | SEC↗ |
| RCEL AVITA Medical, Inc. | A Award deriv | 2022-09-01 | 2022-09-06 | 3,450 | — | $0 | 6,900 | SEC↗ |
| RCEL AVITA Medical, Inc. | A Award | 2022-09-01 | 2022-09-06 | 2,980 | — | $0 | 300,983 | SEC↗ |
| RCEL AVITA Medical, Inc. | J Other | 2022-06-01 | 2022-06-02 | 23,754 | — | $0 | 297,958 | SEC↗ |
| RCEL AVITA Medical, Inc. | S Sale | 2022-02-24 | 2022-02-25 | 10,812 | $8.74 | $94.5K | 321,712 | SEC↗ |
| RCEL AVITA Medical, Inc. | A Award deriv | 2022-02-23 | 2022-02-25 | 3,450 | — | $0 | 3,450 | SEC↗ |
| RCEL AVITA Medical, Inc. | A Award | 2022-02-23 | 2022-02-25 | 5,960 | — | $0 | 332,524 | SEC↗ |
| RCEL AVITA Medical, Inc. | A Award | 2022-02-23 | 2022-02-25 | 23,753 | — | $0 | 326,564 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2022-01-07 | 2022-01-07 | 6,400 | — | $0 | 91,900 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-01-03 | 2022-01-04 | 2,628 | $64.30 | $169.0K | 87,372 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-01-03 | 2022-01-04 | 272 | $66.25 | $18.0K | 85,500 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2022-01-03 | 2022-01-04 | 1,600 | $65.12 | $104.2K | 85,772 | SEC↗ |
| RCEL AVITA Medical, Inc. | A Award deriv | 2021-12-22 | 2021-12-27 | 13,800 | — | $0 | 13,800 | SEC↗ |
| RCEL AVITA Medical, Inc. | A Award deriv | 2021-12-22 | 2021-12-27 | 13,800 | — | $0 | 13,800 | SEC↗ |
| RCEL AVITA Medical, Inc. | A Award deriv | 2021-12-22 | 2021-12-27 | 13,800 | — | $0 | 13,800 | SEC↗ |
| RCEL AVITA Medical, Inc. | A Award | 2021-12-22 | 2021-12-27 | 23,820 | — | $0 | 278,991 | SEC↗ |
| RCEL AVITA Medical, Inc. | A Award | 2021-12-22 | 2021-12-27 | 23,800 | — | $0 | 255,171 | SEC↗ |
| RCEL AVITA Medical, Inc. | A Award | 2021-12-22 | 2021-12-27 | 23,820 | — | $0 | 302,811 | SEC↗ |
| RCEL AVITA Medical, Inc. | A Award | 2021-09-01 | 2021-09-07 | 23,754 | — | $0 | 248,858 | SEC↗ |
| RCEL AVITA Medical, Inc. | S Sale | 2021-09-01 | 2021-09-07 | 11,220 | $20.68 | $232.0K | 237,638 | SEC↗ |
| RCEL AVITA Medical, Inc. | S Sale | 2021-06-02 | 2021-06-04 | 23,000 | $17.33 | $398.6K | 225,104 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2021-01-04 | 2021-01-05 | 4,000 | $76.09 | $304.4K | 90,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2021-01-01 | 2021-01-05 | 9,000 | — | $0 | 94,000 | SEC↗ |
| RCEL Avita Therapeutics, Inc. | S Sale | 2020-09-16 | 2020-09-16 | 9,000 | $27.41 | $246.7K | 425,087 | SEC↗ |
| RCEL Avita Therapeutics, Inc. | S Sale | 2020-09-15 | 2020-09-16 | 23,769 | $27.23 | $647.2K | 434,087 | SEC↗ |
| RCEL Avita Therapeutics, Inc. | A Award | 2020-09-14 | 2020-09-16 | 68,504 | — | $0 | 472,948 | SEC↗ |
| RCEL Avita Therapeutics, Inc. | S Sale | 2020-09-14 | 2020-09-16 | 15,092 | $26.99 | $407.3K | 457,856 | SEC↗ |
| RCEL Avita Therapeutics, Inc. | S Sale | 2020-09-11 | 2020-09-11 | 20,000 | $26.02 | $520.4K | 404,444 | SEC↗ |
| RCEL Avita Therapeutics, Inc. | S Sale | 2020-09-10 | 2020-09-11 | 7,128 | $26.26 | $187.2K | 424,444 | SEC↗ |
| RCEL Avita Therapeutics, Inc. | A Award deriv | 2020-09-09 | 2020-09-11 | 25,000 | — | $0 | 150,000 | SEC↗ |
| RCEL Avita Therapeutics, Inc. | A Award | 2020-09-09 | 2020-09-11 | 83,333 | — | $0 | 431,572 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-05-14 | 2020-05-18 | 7,000 | — | $0 | 70,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-05-14 | 2020-05-18 | 15,000 | — | $0 | 50,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-05-14 | 2020-05-18 | 5,000 | — | $0 | 65,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-05-14 | 2020-05-18 | 10,000 | — | $0 | 40,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-05-14 | 2020-05-18 | 25,000 | — | $0 | 0 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise deriv | 2020-05-14 | 2020-05-18 | 15,000 | — | $0 | 25,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-05-14 | 2020-05-18 | 5,000 | $2.01 | $10.0K | 20,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-05-14 | 2020-05-18 | 7,000 | $4.75 | $33.3K | 15,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-05-14 | 2020-05-18 | 25,000 | $4.20 | $105.0K | 85,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-05-14 | 2020-05-18 | 15,000 | $5.19 | $77.8K | 60,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-05-14 | 2020-05-18 | 10,000 | $2.62 | $26.2K | 45,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | M Exercise | 2020-05-14 | 2020-05-18 | 15,000 | $2.19 | $32.9K | 35,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 29,900 | $35.71 | $1.07M | 14,100 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 6,100 | $36.42 | $222.2K | 8,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2020-01-01 | 2020-01-03 | 8,000 | — | $0 | 44,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-09-11 | 2019-09-11 | 85,000 | $30.00 | $2.55M | 36,000 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | S Sale | 2019-09-09 | 2019-09-11 | 100,000 | $28.90 | $2.89M | 121,000 | SEC↗ |
| ARMP Armata Pharmaceuticals, In | A Award deriv | 2019-05-22 | 2019-05-24 | 27,383 | — | $0 | 27,383 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2019-01-01 | 2019-01-03 | 36,000 | — | $0 | 221,000 | SEC↗ |
| APHB AmpliPhi Biosciences Corp | P Buy | 2018-03-22 | 2018-03-26 | 181,820 | $1.10 | $200.0K | 411,105 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2018-01-01 | 2018-01-03 | 30,000 | — | $0 | 185,000 | SEC↗ |
| APHB AmpliPhi Biosciences Corp | P Buy | 2017-09-19 | 2018-03-26 | 105,015 | — | $0 | 229,285 | SEC↗ |
| APHB AmpliPhi Biosciences Corp | A Award deriv | 2017-09-07 | 2017-09-12 | 10,900 | — | $0 | 10,900 | SEC↗ |
| APHB AmpliPhi Biosciences Corp | P Buy | 2017-06-29 | 2018-03-26 | 5,757 | — | $0 | 124,270 | SEC↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, | A Award | 2017-01-01 | 2017-01-04 | 80,000 | — | $0 | 155,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award | 2016-01-01 | 2016-01-04 | 30,000 | — | $0 | 75,000 | SEC↗ |
| APHB AmpliPhi Biosciences Corp | A Award deriv | 2015-09-21 | 2015-09-23 | 12,800 | — | $0 | 12,800 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award | 2015-03-04 | 2015-03-06 | 30,000 | — | $0 | 45,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award | 2014-02-06 | 2014-02-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2013-09-21 | 2013-09-24 | 7,000 | — | $0 | 77,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2013-05-06 | 2013-05-08 | 5,000 | — | $0 | 70,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2013-03-21 | 2013-04-01 | 15,000 | — | $0 | 65,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2013-03-21 | 2013-03-25 | 15,000 | — | $0 | 65,000 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2012-09-28 | 2012-10-02 | 10,000 | — | $0 | 50,000 | SEC↗ |
| PARD PONIARD PHARMACEUTICALS, I | S Sale | 2012-03-27 | 2012-03-27 | 1,599 | $0.83 | $1.3K | 8,920 | SEC↗ |
| PARD PONIARD PHARMACEUTICALS, I | M Exercise deriv | 2012-03-26 | 2012-03-27 | 2,800 | — | $0 | 0 | SEC↗ |
| PARD PONIARD PHARMACEUTICALS, I | M Exercise | 2012-03-26 | 2012-03-27 | 2,800 | — | $0 | 10,519 | SEC↗ |
| ARWR ARROWHEAD RESEARCH CORP | A Award deriv | 2012-02-16 | 2012-02-21 | 15,000 | — | $0 | 40,000 | SEC↗ |
| PARD PONIARD PHARMACEUTICALS, I | S Sale | 2012-02-16 | 2012-02-17 | 6,346 | $0.87 | $5.5K | 7,719 | SEC↗ |
| PARD PONIARD PHARMACEUTICALS, I | M Exercise deriv | 2012-02-15 | 2012-02-17 | 12,019 | — | $0 | 0 | SEC↗ |
| PARD PONIARD PHARMACEUTICALS, I | M Exercise | 2012-02-15 | 2012-02-17 | 12,019 | — | $0 | 14,065 | SEC↗ |